Evidence map›Paper›PMID 30835844›Full record

ArticleThe Medical journal of Australia2019

Recruiting general practice patients for large clinical trials: lessons from the Aspirin in Reducing Events in the Elderly (ASPREE) study.

Jessica E Lockery, Taya A Collyer, Walter P Abhayaratna, Sharyn M Fitzgerald, John J McNeil, Mark R Nelson, Suzanne G Orchard, Christopher Reid, Nigel P Stocks, Ruth E Trevaks and 1 more

Abstract read
In one paragraph

Article in The Medical journal of Australia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
16.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Jessica E LockeryMonash University, Melbourne, VIC.ORCID 0000-0001-6664-1239
Taya A CollyerMonash University, Melbourne, VIC.
Walter P AbhayaratnaCollege of Health and Medicine, Australian National University School of Clinical Medicine, Canberra, ACT.
Sharyn M FitzgeraldMonash University, Melbourne, VIC.
John J McNeilMonash University, Melbourne, VIC.
Mark R NelsonUniversity of Tasmania, Hobart, TAS.
Suzanne G OrchardMonash University, Melbourne, VIC.
Christopher ReidCurtin University, Perth, WA.
Nigel P StocksUniversity of Adelaide, Adelaide, SA.
Ruth E TrevaksMonash University, Melbourne, VIC.
Robyn WoodsMonash University, Melbourne, VIC.
Monash University · AUAustralian National University · AUThe University of Adelaide · AUUniversity of Tasmania · AU

Funding

ASPirin in Reducing Events in the ElderlyU01AG029824 · NIA · HENNEPIN HEALTHCARE RESEARCH INSTITUTE · PI MCNEIL, JOHN JAMES, MURRAY, ANNE M · 2009 to 2018
$64.6M
Main Administrative CoreU19AG062682 · NIA · HENNEPIN HEALTHCARE RESEARCH INSTITUTE · PI CHAN, ANDREW T, MCNEIL, JOHN JAMES · 2019 to 2023
$42.9M
NIA NIH HHS U01 AG029824NIA NIH HHS U19 AG062682
6 · The paper itself

Abstract

objectiveTo assess the factors that contributed to the successful completion of recruitment for the largest clinical trial ever conducted in Australia, the Aspirin in Reducing Events in the Elderly (ASPREE) study.

designEnrolment of GPs; identification of potential participants in general practice databases; screening of participants. SETTING,

participantsSelected general practices across southeast Australia (Tasmania, Victoria, Australian Capital Territory, New South Wales, South Australia). MAJOR OUTCOMES: Numbers of patients per GP screened and randomised to participation; geographic and demographic factors that influenced screening and randomising of patients.

results2717 of 5833 GPs approached (47%) enrolled to recruit patients for the study; 2053 (76%) recruited at least one randomised participant. The highest randomised participant rate per GP was for Tasmania (median, 5; IQR, 1-11), driven by the high rate of participant inclusion at phone screening. GPs in inner regional (adjusted odds ratio [aOR], 1.45; 95% CI, 1.14-1.84) and outer regional areas (aOR, 1.86; 95% CI, 1.19-2.88) were more likely than GPs in major cities to recruit at least one randomised participant. GPs in areas with a high proportion of people aged 70 years or more were more likely to randomise at least one participant (per percentage point increase: aOR, 1.10; 95% CI, 1.05-1.15). The number of randomised patients declined with time from GP enrolment to first randomisation.

conclusionGeneral practice can be a rich environment for research when barriers to recruitment are overcome. Including regional GPs and focusing efforts in areas with the highest proportions of potentially eligible participants improves recruitment. The success of ASPREE attests to the clinical importance of its research question for Australian GPs.

Indexed as

Patient SelectionAgedAged, 80 and overAspirinAustraliaCardiovascular DiseasesFemaleGeneral PracticeGeneral PractitionersGeographyHumansMaleRandomized Controlled Trials as TopicAspirinGeneral practiceRandomized controlled trial as topicResearch design

Identifiers

PMID30835844
PMCPMC6456041
OpenAlexW2913360616

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.